Gasdermin E-mediated lysosome-pore formation curbs pancreatic ductal adenocarcinoma via IFN-γ/IFN-β/TGF-β cocktail mRNA-LNP

Key Points

• Gasdermin E-mediated lysosome-pore formation curbs pancreatic ductal adenocarcinoma effectively.
• A key metric shows significant reduction in tumor growth when treated with an mRNA-LNP cocktail.
• Analysis used a combination of IFN-γ, IFN-β, and TGF-β to assess the impact on cancer progression.
• Potential clinical implications highlight a novel approach to target pancreatic cancer, requiring further validation.